Skip to main content

Advertisement

Table 1 Study population characteristics

From: Effects of paraoxonase activity and gene polymorphism on coronary vasomotion

Variable (n= 19) Mean ± SD or median (IQR) or n(%)
Age (years) 57.6 ± 9.8
Sex (% of women) 8 Women/11 men (42% women)
Weight (kg) 77 (66-94)
Body mass index (kg/m2) 25.9 (22.1-30.9)
Current smoking 3 (16%)
Hypertension 15 (80%)
Dyslipidemia 12 (63%)
Family history of early CHD 0 (0%)
Overall cholesterol (mmol/L) 4.2 ± 0.8
LDL-cholesterol (mmol/L) 2.3 ± 0.7
HDL-cholesterol (mmol/L) 1.2 ± 0.3
Triglyceride levels (mmol/L) 1.2 (0.9-1.8)
Fastening insulin (μU/mL) 10.8 (6.9-21.6)
Fastening glucose (mmol/L) 5.8 (5.4-7.5)
HOMA-IR (1) 3.3 (1.8-5.0)
hsCRP (mg/L, normal < 5 mg/L) 1.1 (0.4-2.8)
PON1 (U/L; n = 18) 79.3 ± 71.7
Arylesterase (U/L; n = 18) 41.0 (38.9-48.3)
Ratio hsCRP/PON1 × 1,000 (mg/U; n = 18) 47.1 (7.3-312)
  1. IQR, interquartile range; CHD, coronary heart disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; hsCRP, high sensitivity C-reactive protein.